98 related articles for article (PubMed ID: 3279631)
1. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
Foegh ML; Lim K; Douglas F; Turk J; Helfrich GB; Taher SA; Alijani MR
Transplant Proc; 1988 Feb; 20(1 Suppl 1):424-7. PubMed ID: 3279631
[No Abstract] [Full Text] [Related]
2. Thromboxane and leukotrienes in clinical and experimental transplant rejection.
Foegh ML; Alijani MR; Helfrich GB; Khirabadi BS; Goldman MH; Lower RR; Ramwell PW
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():209-17. PubMed ID: 2988310
[No Abstract] [Full Text] [Related]
3. Modification of rat skin allograft rejection by inhibition of thromboxane synthesis.
Ruiz P; Woodson C; Rey L
Transplantation; 1992 Aug; 54(2):385-8. PubMed ID: 1496552
[No Abstract] [Full Text] [Related]
4. Suppression of S-antigen-induced experimental autoimmune uveoretinitis in Lewis rats by oral administration with CGS-13080, a thromboxane synthetase inhibitor.
Li Q; Lopez JS; Caspi RR; Roberge FG; Nussenblatt RB; Kador PF; Chan CC
Exp Eye Res; 1993 Nov; 57(5):601-8. PubMed ID: 8282047
[TBL] [Abstract][Full Text] [Related]
5. Effects of CGS-13080, a thromboxane inhibitor, on pulmonary vascular resistance in patients after mitral valve replacement surgery.
Kim YD; Foegh ML; Wallace RB; Ng L; Ahmed SW; Katz NM; Siegelman R; Franco K; Douglas F; Ku E
Circulation; 1988 Sep; 78(3 Pt 2):I44-50. PubMed ID: 3409518
[TBL] [Abstract][Full Text] [Related]
6. Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and excretion in healthy dogs.
Longhofer SL; Johnson HC; Culham CA; Schultz KT; Grauer GF
Am J Vet Res; 1990 Nov; 51(11):1746-50. PubMed ID: 2240799
[TBL] [Abstract][Full Text] [Related]
7. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients.
Chouinard ML; Martin LL; Coffman T; Hamilton BH; Linberg LF; Pamidi A; Simke JP; Rakhit A
Clin Pharmacol Ther; 1992 Dec; 52(6):597-604. PubMed ID: 1458769
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane synthesis inhibition and renal allograft function.
Anderson C; Jendrisak M; Brunt E; Tobimatsu M; Murphy M; Sicard G; Mangino M
Transplant Proc; 1989 Feb; 21(1 Pt 1):1161-4. PubMed ID: 2650085
[TBL] [Abstract][Full Text] [Related]
11. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity.
Smith SR; Kubacki VB; Rakhit A; Martin LL; Schaffer AV; Jasani MK; Hefty DJ; Johnston T; Cannon C; Bennett WM
Transplantation; 1993 Dec; 56(6):1422-6. PubMed ID: 8279014
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane synthetase inhibition in primary pulmonary hypertension.
Rich S; Hart K; Kieras K; Brundage BH
Chest; 1987 Mar; 91(3):356-60. PubMed ID: 3545698
[TBL] [Abstract][Full Text] [Related]
13. Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
Tanabe K; Toma H; Sagara R; Takahashi K; Teraoka S; Ota K
Transplant Proc; 1989 Feb; 21(1 Pt 1):293-5. PubMed ID: 2650124
[No Abstract] [Full Text] [Related]
14. Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs.
DeCampli WM; Goodwin D; Kosek JC; Handen CE; Mitchell RS; Miller DC
Ann Thorac Surg; 1986 Dec; 42(6):690-6. PubMed ID: 3789860
[TBL] [Abstract][Full Text] [Related]
15. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
[TBL] [Abstract][Full Text] [Related]
16. Fetal and maternal response to intravenous infusion of a thromboxane synthetase inhibitor.
Cardin JP; Ross MG; Ervin MG; Schaffer AV; Douglas FL; Simke JP
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1345-9. PubMed ID: 2220946
[TBL] [Abstract][Full Text] [Related]
17. (E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151): a potent, specific thromboxane A2 synthetase inhibitor.
Nishikawa K; Terashita Z; Imamoto T; Imura Y; Hirata M; Terao S
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():523-5. PubMed ID: 2936160
[No Abstract] [Full Text] [Related]
18. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P
Transplant Proc; 1988 Jun; 20(3 Suppl 3):658-64. PubMed ID: 3164534
[No Abstract] [Full Text] [Related]
19. Comparison of the effects of a thromboxane synthase inhibitor or prostacyclin in combination with a phosphodiesterase inhibitor for prevention of experimental thrombosis and sudden death in rabbits.
Smith EF; Egan JW
J Pharmacol Exp Ther; 1987 Jun; 241(3):855-60. PubMed ID: 3298621
[TBL] [Abstract][Full Text] [Related]
20. Long-term renal preservation and prevention of acute tubular necrosis by inhibition of arachidonate metabolism.
Schilling M; Saunder A; Southard JH; Belzer FO
Transplant Proc; 1993 Aug; 25(4):2534-5. PubMed ID: 8356657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
